PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $21,000 | -40.0% | 8,472 | -32.2% | 0.00% | – |
| Q2 2020 | $35,000 | +775.0% | 12,499 | +725.6% | 0.00% | – |
| Q1 2020 | $4,000 | -99.8% | 1,514 | -99.8% | 0.00% | -100.0% |
| Q4 2019 | $2,646,000 | +80.2% | 815,411 | +20.0% | 0.00% | +100.0% |
| Q3 2019 | $1,468,000 | -31.6% | 679,592 | -0.6% | 0.00% | -50.0% |
| Q2 2019 | $2,147,000 | -16.2% | 683,588 | -0.8% | 0.00% | 0.0% |
| Q1 2019 | $2,563,000 | +44.6% | 689,016 | +12.8% | 0.00% | 0.0% |
| Q4 2018 | $1,772,000 | +10.2% | 610,986 | -0.0% | 0.00% | +100.0% |
| Q3 2018 | $1,608,000 | +12.7% | 611,049 | +0.2% | 0.00% | 0.0% |
| Q2 2018 | $1,427,000 | -54.4% | 610,069 | -42.6% | 0.00% | -66.7% |
| Q1 2018 | $3,127,000 | +28.6% | 1,063,577 | +19.8% | 0.00% | +50.0% |
| Q4 2017 | $2,432,000 | +83.4% | 887,701 | +126.9% | 0.00% | +100.0% |
| Q3 2017 | $1,326,000 | +37.6% | 391,186 | +0.3% | 0.00% | 0.0% |
| Q2 2017 | $964,000 | +7.6% | 390,186 | -1.2% | 0.00% | 0.0% |
| Q1 2017 | $896,000 | +1198.6% | 394,811 | +1158.9% | 0.00% | – |
| Q4 2016 | $69,000 | -36.7% | 31,361 | -3.5% | 0.00% | – |
| Q3 2016 | $109,000 | -28.8% | 32,513 | -33.3% | 0.00% | – |
| Q2 2016 | $153,000 | +2.0% | 48,750 | +7.5% | 0.00% | – |
| Q1 2016 | $150,000 | -44.4% | 45,330 | -40.2% | 0.00% | – |
| Q4 2015 | $270,000 | -51.4% | 75,839 | -31.2% | 0.00% | -100.0% |
| Q3 2015 | $555,000 | -97.1% | 110,284 | -96.3% | 0.00% | -95.5% |
| Q2 2015 | $18,937,000 | +354.7% | 2,945,241 | +397.4% | 0.02% | +340.0% |
| Q1 2015 | $4,165,000 | -76.9% | 592,083 | -74.6% | 0.01% | -75.0% |
| Q4 2014 | $17,998,000 | +62.5% | 2,334,410 | +57.4% | 0.02% | +53.8% |
| Q3 2014 | $11,076,000 | -8.8% | 1,482,821 | +18.2% | 0.01% | -7.1% |
| Q2 2014 | $12,141,000 | +54.3% | 1,254,263 | +32.5% | 0.01% | +40.0% |
| Q1 2014 | $7,868,000 | +28.7% | 946,718 | +30.7% | 0.01% | +25.0% |
| Q4 2013 | $6,115,000 | +1918.2% | 724,434 | +1804.0% | 0.01% | – |
| Q3 2013 | $303,000 | +1.0% | 38,048 | -2.0% | 0.00% | -100.0% |
| Q2 2013 | $300,000 | – | 38,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |